Vanguard Fiduciary Trust
PHIO icon

Vanguard Fiduciary Trust’s Phio Pharmaceuticals PHIO Stock Holding History

Vanguard Fiduciary Trust’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.1K Hold
38,169
– – ﹤0.01% 3915
2026
Q1 		$46.6K Buy
+38,169
New +$43.5K ﹤0.01% 3837

Other funds holding PHIO

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Vanguard Fiduciary Trust's PHIO Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Phio Pharmaceuticals (PHIO) position steady in Q2 2026 at 38,169 shares worth $39.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3915.

Vanguard Fiduciary Trust first reported a position in PHIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $46.6K in Q1 2026. 24 funds tracked by Wall St. Rank hold PHIO as of Q2 2026.

  • Vanguard Fiduciary Trust held 38,169 shares of Phio Pharmaceuticals worth $39.1K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Phio Pharmaceuticals share count unchanged in Q2 2026.
  • Phio Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3915 holding.
  • Vanguard Fiduciary Trust first reported a position in Phio Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Phio Pharmaceuticals position peaked at $46.6K in Q1 2026.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.